 | • レポートコード：MRC2Q12-18268 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、性感染症検査のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 性感染症検査のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 性感染症検査の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 性感染症検査のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの性感染症検査の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の性感染症検査の売上および2028年までの予測に焦点を当てています。 性感染症検査のグローバル主要企業には、Abbott Laboratories、Becton Dickinson and Company、Bio-Rad Laboratories、bioMerieux S.A.、Danaher Corporation、DiaSorin、Hologic、OraSure Technologies、Qiagen、Roche Holdings AG、Thermo Fisher Scientificなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 性感染症検査市場は、タイプとアプリケーションによって区分されます。世界の性感染症検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 クラミジア検査、淋病検査、梅毒検査、人間パピローマウイルス（HPV）検査、単純ヘルペスウイルス（HSV）検査、人間免疫不全ウイルス（HIV/AIDS）検査、下疳検査、その他 【アプリケーション別セグメント】 実験室試験、ポイントオブケア（POC）試験、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 性感染症検査製品概要 - タイプ別市場（クラミジア検査、淋病検査、梅毒検査、人間パピローマウイルス（HPV）検査、単純ヘルペスウイルス（HSV）検査、人間免疫不全ウイルス（HIV/AIDS）検査、下疳検査、その他） - アプリケーション別市場（実験室試験、ポイントオブケア（POC）試験、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の性感染症検査販売量予測2017-2028 - 世界の性感染症検査売上予測2017-2028 - 性感染症検査の地域別販売量 - 性感染症検査の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別性感染症検査販売量 - 主要メーカー別性感染症検査売上 - 主要メーカー別性感染症検査価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（クラミジア検査、淋病検査、梅毒検査、人間パピローマウイルス（HPV）検査、単純ヘルペスウイルス（HSV）検査、人間免疫不全ウイルス（HIV/AIDS）検査、下疳検査、その他） - 性感染症検査のタイプ別販売量 - 性感染症検査のタイプ別売上 - 性感染症検査のタイプ別価格 ・アプリケーション別市場規模（実験室試験、ポイントオブケア（POC）試験、その他） - 性感染症検査のアプリケーション別販売量 - 性感染症検査のアプリケーション別売上 - 性感染症検査のアプリケーション別価格 ・北米市場 - 北米の性感染症検査市場規模（タイプ別、アプリケーション別） - 主要国別の性感染症検査市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの性感染症検査市場規模（タイプ別、アプリケーション別） - 主要国別の性感染症検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の性感染症検査市場規模（タイプ別、アプリケーション別） - 主要国別の性感染症検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の性感染症検査市場規模（タイプ別、アプリケーション別） - 主要国別の性感染症検査市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの性感染症検査市場規模（タイプ別、アプリケーション別） - 主要国別の性感染症検査市場規模（トルコ、サウジアラビア） ・企業情報 Abbott Laboratories、Becton Dickinson and Company、Bio-Rad Laboratories、bioMerieux S.A.、Danaher Corporation、DiaSorin、Hologic、OraSure Technologies、Qiagen、Roche Holdings AG、Thermo Fisher Scientific ・産業チェーン及び販売チャネル分析 - 性感染症検査の産業チェーン分析 - 性感染症検査の原材料 - 性感染症検査の生産プロセス - 性感染症検査の販売及びマーケティング - 性感染症検査の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 性感染症検査の産業動向 - 性感染症検査のマーケットドライバー - 性感染症検査の課題 - 性感染症検査の阻害要因 ・主な調査結果 |
Sexually Transmitted Disease Testing is used to find out if you have been infected with an STD. Testing can help you get the treatment you need and may help prevent the spread of disease.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Sexually Transmitted Disease Testing estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Sexually Transmitted Disease Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Sexually Transmitted Disease Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Sexually Transmitted Disease Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Sexually Transmitted Disease Testing include Abbott Laboratories, Becton Dickinson and Company, Bio-Rad Laboratories, bioMerieux S.A., Danaher Corporation, DiaSorin, Hologic, OraSure Technologies and Qiagen, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Sexually Transmitted Disease Testing companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Sexually Transmitted Disease Testing market. Further, it explains the major drivers and regional dynamics of the global Sexually Transmitted Disease Testing market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abbott Laboratories
Becton Dickinson and Company
Bio-Rad Laboratories
bioMerieux S.A.
Danaher Corporation
DiaSorin
Hologic
OraSure Technologies
Qiagen
Roche Holdings AG
Thermo Fisher Scientific
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Sexually Transmitted Disease Testing Segment by Type
Chlamydia Test
Gonorrhea Test
Syphillis Test
Human Papillomavirus (HPV) Test
Herpes Simplex Virus (HSV) Test
Human Immunodeficiency Virus (HIV/AIDS) Test
Chancroid Test
Others
Sexually Transmitted Disease Testing Segment by Application
Laboratory Testing
Point-of-Care (POC) Testing
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Sexually Transmitted Disease Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Sexually Transmitted Disease Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Sexually Transmitted Disease Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sexually Transmitted Disease Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sexually Transmitted Disease Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Sexually Transmitted Disease Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Sexually Transmitted Disease Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, Becton Dickinson and Company, Bio-Rad Laboratories, bioMerieux S.A., Danaher Corporation, DiaSorin, Hologic, OraSure Technologies and Qiagen, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Sexually Transmitted Disease Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sexually Transmitted Disease Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sexually Transmitted Disease Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Disease Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chlamydia Test
1.2.3 Gonorrhea Test
1.2.4 Syphillis Test
1.2.5 Human Papillomavirus (HPV) Test
1.2.6 Herpes Simplex Virus (HSV) Test
1.2.7 Human Immunodeficiency Virus (HIV/AIDS) Test
1.2.8 Chancroid Test
1.2.9 Others
1.3 Market by Application
1.3.1 Global Sexually Transmitted Disease Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Laboratory Testing
1.3.3 Point-of-Care (POC) Testing
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Disease Testing Market Perspective (2017-2028)
2.2 Sexually Transmitted Disease Testing Growth Trends by Region
2.2.1 Sexually Transmitted Disease Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Sexually Transmitted Disease Testing Historic Market Size by Region (2017-2022)
2.2.3 Sexually Transmitted Disease Testing Forecasted Market Size by Region (2023-2028)
2.3 Sexually Transmitted Disease Testing Market Dynamics
2.3.1 Sexually Transmitted Disease Testing Industry Trends
2.3.2 Sexually Transmitted Disease Testing Market Drivers
2.3.3 Sexually Transmitted Disease Testing Market Challenges
2.3.4 Sexually Transmitted Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Disease Testing Players by Revenue
3.1.1 Global Top Sexually Transmitted Disease Testing Players by Revenue (2017-2022)
3.1.2 Global Sexually Transmitted Disease Testing Revenue Market Share by Players (2017-2022)
3.2 Global Sexually Transmitted Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sexually Transmitted Disease Testing Revenue
3.4 Global Sexually Transmitted Disease Testing Market Concentration Ratio
3.4.1 Global Sexually Transmitted Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease Testing Revenue in 2021
3.5 Sexually Transmitted Disease Testing Key Players Head office and Area Served
3.6 Key Players Sexually Transmitted Disease Testing Product Solution and Service
3.7 Date of Enter into Sexually Transmitted Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sexually Transmitted Disease Testing Breakdown Data by Type
4.1 Global Sexually Transmitted Disease Testing Historic Market Size by Type (2017-2022)
4.2 Global Sexually Transmitted Disease Testing Forecasted Market Size by Type (2023-2028)
5 Sexually Transmitted Disease Testing Breakdown Data by Application
5.1 Global Sexually Transmitted Disease Testing Historic Market Size by Application (2017-2022)
5.2 Global Sexually Transmitted Disease Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Sexually Transmitted Disease Testing Market Size (2017-2028)
6.2 North America Sexually Transmitted Disease Testing Market Size by Type
6.2.1 North America Sexually Transmitted Disease Testing Market Size by Type (2017-2022)
6.2.2 North America Sexually Transmitted Disease Testing Market Size by Type (2023-2028)
6.2.3 North America Sexually Transmitted Disease Testing Market Share by Type (2017-2028)
6.3 North America Sexually Transmitted Disease Testing Market Size by Application
6.3.1 North America Sexually Transmitted Disease Testing Market Size by Application (2017-2022)
6.3.2 North America Sexually Transmitted Disease Testing Market Size by Application (2023-2028)
6.3.3 North America Sexually Transmitted Disease Testing Market Share by Application (2017-2028)
6.4 North America Sexually Transmitted Disease Testing Market Size by Country
6.4.1 North America Sexually Transmitted Disease Testing Market Size by Country (2017-2022)
6.4.2 North America Sexually Transmitted Disease Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Sexually Transmitted Disease Testing Market Size (2017-2028)
7.2 Europe Sexually Transmitted Disease Testing Market Size by Type
7.2.1 Europe Sexually Transmitted Disease Testing Market Size by Type (2017-2022)
7.2.2 Europe Sexually Transmitted Disease Testing Market Size by Type (2023-2028)
7.2.3 Europe Sexually Transmitted Disease Testing Market Share by Type (2017-2028)
7.3 Europe Sexually Transmitted Disease Testing Market Size by Application
7.3.1 Europe Sexually Transmitted Disease Testing Market Size by Application (2017-2022)
7.3.2 Europe Sexually Transmitted Disease Testing Market Size by Application (2023-2028)
7.3.3 Europe Sexually Transmitted Disease Testing Market Share by Application (2017-2028)
7.4 Europe Sexually Transmitted Disease Testing Market Size by Country
7.4.1 Europe Sexually Transmitted Disease Testing Market Size by Country (2017-2022)
7.4.2 Europe Sexually Transmitted Disease Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Disease Testing Market Size (2017-2028)
8.2 Asia-Pacific Sexually Transmitted Disease Testing Market Size by Type
8.2.1 Asia-Pacific Sexually Transmitted Disease Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Sexually Transmitted Disease Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Sexually Transmitted Disease Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Sexually Transmitted Disease Testing Market Size by Application
8.3.1 Asia-Pacific Sexually Transmitted Disease Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Sexually Transmitted Disease Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Sexually Transmitted Disease Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Sexually Transmitted Disease Testing Market Size by Region
8.4.1 Asia-Pacific Sexually Transmitted Disease Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Sexually Transmitted Disease Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sexually Transmitted Disease Testing Market Size (2017-2028)
9.2 Latin America Sexually Transmitted Disease Testing Market Size by Type
9.2.1 Latin America Sexually Transmitted Disease Testing Market Size by Type (2017-2022)
9.2.2 Latin America Sexually Transmitted Disease Testing Market Size by Type (2023-2028)
9.2.3 Latin America Sexually Transmitted Disease Testing Market Share by Type (2017-2028)
9.3 Latin America Sexually Transmitted Disease Testing Market Size by Application
9.3.1 Latin America Sexually Transmitted Disease Testing Market Size by Application (2017-2022)
9.3.2 Latin America Sexually Transmitted Disease Testing Market Size by Application (2023-2028)
9.3.3 Latin America Sexually Transmitted Disease Testing Market Share by Application (2017-2028)
9.4 Latin America Sexually Transmitted Disease Testing Market Size by Country
9.4.1 Latin America Sexually Transmitted Disease Testing Market Size by Country (2017-2022)
9.4.2 Latin America Sexually Transmitted Disease Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Disease Testing Market Size (2017-2028)
10.2 Middle East & Africa Sexually Transmitted Disease Testing Market Size by Type
10.2.1 Middle East & Africa Sexually Transmitted Disease Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Sexually Transmitted Disease Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Sexually Transmitted Disease Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Sexually Transmitted Disease Testing Market Size by Application
10.3.1 Middle East & Africa Sexually Transmitted Disease Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Sexually Transmitted Disease Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Sexually Transmitted Disease Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Sexually Transmitted Disease Testing Market Size by Country
10.4.1 Middle East & Africa Sexually Transmitted Disease Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Sexually Transmitted Disease Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Sexually Transmitted Disease Testing Introduction
11.1.4 Abbott Laboratories Revenue in Sexually Transmitted Disease Testing Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Becton Dickinson and Company
11.2.1 Becton Dickinson and Company Company Details
11.2.2 Becton Dickinson and Company Business Overview
11.2.3 Becton Dickinson and Company Sexually Transmitted Disease Testing Introduction
11.2.4 Becton Dickinson and Company Revenue in Sexually Transmitted Disease Testing Business (2017-2022)
11.2.5 Becton Dickinson and Company Recent Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Sexually Transmitted Disease Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in Sexually Transmitted Disease Testing Business (2017-2022)
11.3.5 Bio-Rad Laboratories Recent Developments
11.4 bioMerieux S.A.
11.4.1 bioMerieux S.A. Company Details
11.4.2 bioMerieux S.A. Business Overview
11.4.3 bioMerieux S.A. Sexually Transmitted Disease Testing Introduction
11.4.4 bioMerieux S.A. Revenue in Sexually Transmitted Disease Testing Business (2017-2022)
11.4.5 bioMerieux S.A. Recent Developments
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Details
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Sexually Transmitted Disease Testing Introduction
11.5.4 Danaher Corporation Revenue in Sexually Transmitted Disease Testing Business (2017-2022)
11.5.5 Danaher Corporation Recent Developments
11.6 DiaSorin
11.6.1 DiaSorin Company Details
11.6.2 DiaSorin Business Overview
11.6.3 DiaSorin Sexually Transmitted Disease Testing Introduction
11.6.4 DiaSorin Revenue in Sexually Transmitted Disease Testing Business (2017-2022)
11.6.5 DiaSorin Recent Developments
11.7 Hologic
11.7.1 Hologic Company Details
11.7.2 Hologic Business Overview
11.7.3 Hologic Sexually Transmitted Disease Testing Introduction
11.7.4 Hologic Revenue in Sexually Transmitted Disease Testing Business (2017-2022)
11.7.5 Hologic Recent Developments
11.8 OraSure Technologies
11.8.1 OraSure Technologies Company Details
11.8.2 OraSure Technologies Business Overview
11.8.3 OraSure Technologies Sexually Transmitted Disease Testing Introduction
11.8.4 OraSure Technologies Revenue in Sexually Transmitted Disease Testing Business (2017-2022)
11.8.5 OraSure Technologies Recent Developments
11.9 Qiagen
11.9.1 Qiagen Company Details
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Sexually Transmitted Disease Testing Introduction
11.9.4 Qiagen Revenue in Sexually Transmitted Disease Testing Business (2017-2022)
11.9.5 Qiagen Recent Developments
11.10 Roche Holdings AG
11.10.1 Roche Holdings AG Company Details
11.10.2 Roche Holdings AG Business Overview
11.10.3 Roche Holdings AG Sexually Transmitted Disease Testing Introduction
11.10.4 Roche Holdings AG Revenue in Sexually Transmitted Disease Testing Business (2017-2022)
11.10.5 Roche Holdings AG Recent Developments
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Sexually Transmitted Disease Testing Introduction
11.11.4 Thermo Fisher Scientific Revenue in Sexually Transmitted Disease Testing Business (2017-2022)
11.11.5 Thermo Fisher Scientific Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer